jc
jc

News Center

Check category
/
/
/
J-Valve® debuted at the First China Structural Heart Disease Week

J-Valve® debuted at the First China Structural Heart Disease Week

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-10 13:36
  • Views:

(Summary description)

J-Valve® debuted at the First China Structural Heart Disease Week

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-10 13:36
  • Views:
Information

X

 

X

 

  The first Chinese structural heart disease was held at Fuwai Hospital from September 25 to 30, 2017. During the period, the heart team of Professor Wang Wei of Fuwai Hospital and Professor Wang Jianan, Professor Liu Xianbao of the Second Affiliated Hospital of Zhejiang University Medical College Professor Dong Aiqiang, Huaxi Hospital, Professor Guo Yingjiang completed a total of two J-Valve? through the heart of the hand involved in valve surgery live, the operation team side of the operation with the venue experts to fully communicate in detail to discuss the points, by the General Assembly experts praise. Reported in Zhejiang Second Hospital remote live surgery cases.

 

X

 

  Patient history data
  Patients: male, 79 years old, due to "repeated activities after chest tightness and anxious 10 years, increased by half, admitted to September 24, 2017, examination showed: severe aortic valve insufficiency, arrhythmia I degree atrioventricular block, high Blood pressure, renal insufficiency, poor heart function, age, weakness, condition is heavy, if not dealt with at any time life-threatening, but the patient can not tolerate traditional surgical valve surgery, heart valve team carefully discussed after the minimally invasive catheter Arterial valve replacement.


  Surgery process
  1. After general anesthesia by the left side of the fifth intercostal to do 4cm small incision, showing apex, double purse suture, puncture apex, femoral artery angiography showed severe reflux. ▼

 

X

 

  2. Under the guidance of DSA and TEE implanted with 27mm valve implantation system, and gradually explain and release the world's unique patent-positioning device, safe fall into the aortic valve sinus. ▼

 

X

 

  3. will not open the valve into the positioning device, angiography showed valve and positioning parts shape, good position. ▼

 

X

 

  4. Contrast and ultrasonography confirm the location and shape of the valve and positioning parts, the final release of the valve and withdrawal of the implant device. ▼

 

X

 

  Surgical summary
  The whole operation completed 30 minutes, the valve shape is good, no half-week leakage, no reflux. Participants actively discuss applause.
  J-Valve? is a new generation of interventional valves, which was approved by the State Food and Drug Administration in April 2017. Its indications include aortic stenosis, aortic regurgitation and aortic stenosis Closed is the only one in the world to obtain official approval to treat aortic valve insufficiency of the interventional valve, but also aortic valve disease one-stop solution.

 

X

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息